Ahmedabad-based Dishman Pharmaceuticals and Chemicals Ltd said on Wednesday it will acquire the pharmaceutical services business of US-based Solutia Inc for $74.5 million.
Besides looking to grow through the inorganic route, the company has embarked on an expansion strategy by planning to set up four manufacturing plants at Bavla in Gujarat.
Dishman Pharmaceuticals & Chemicals has acquired 80,000 sq.mt industrial plot in Shanghai Chemical Industry Park.\n
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
The rally in most of these stocks is partly attributed to impressive financial performance.
The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.
Sensex ended strong, Tata Steel, HUL climb higher.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances